CVS Health Corp (IT:1CVS)
MILAN:1CVS

CVS Health (1CVS) Stock Price & Analysis

0 Followers

1CVS Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€49.34 - €74.68
Previous Close€55.59
Volume0.00
Average Volume (3M)104.00
Market Cap
€70.48B
Enterprise Value€133.83B
Total Cash (Recent Filing)$13.09B
Total Debt (Recent Filing)$81.79B
Price to Earnings (P/E)
BetaN/A
Aug 07, 2024
Dividend Yield4.16%
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,255,372,972
10 Day Avg. Volume35
30 Day Avg. Volume104
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-1.75
Price to Sales (P/S)0.20
Price to Cash Flow (P/CF)-7.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit2.46
Enterprise Value/Ebitda10.59
Forecast
Price Target Upside11.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering20

Bulls Say, Bears Say

Bulls Say
Financial PerformanceThe improvement in Aetna's Stars ratings should translate to a $700 million AOI boost next year.
Growth OpportunitiesCVS saw strong MA membership growth for FY24.
Strategic PartnershipsA potential CVS-private equity partnership would help lessen the capital investment burden associated with the buildout of the OSH clinic base.
Bears Say
EarningsThe magnitude of CVS's miss was worse than expected and prompted management to cut FY24 EPS guide and reset down its earnings power baseline.
Medicare AdvantageThe Medicare Advantage business will require significant attention over the next few years to get back on track.
Pharmacy ServicesPharmacy & Consumer Wellness saw an additional wrench thrown into profit questions with the recent WBA underperformance, potentially exacerbated by fluctuations in NADAC pricing that could further weigh on already pressured reimbursement.
---

Financials

Annual

Ownership Overview

0.00%0.00%3.17%96.83%
3.17% Other Institutional Investors
96.83% Public Companies and
Individual Investors

Website Traffic

The estimated number of people who visited one or more of the websites owned by CVS Health
Desktop Users
Mobile Users

1CVS FAQ

What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €49.34 and its highest was €74.68 in the past 12 months.
    What is CVS Health Corp’s market cap?
    Currently, no data Available
    When is CVS Health Corp’s upcoming earnings report date?
    CVS Health Corp’s upcoming earnings report date is Aug 07, 2024 which is in 9 days.
      How were CVS Health Corp’s earnings last quarter?
      CVS Health Corp released its earnings results on May 01, 2024. The company reported €1.205 earnings per share for the quarter, missing the consensus estimate of €1.559 by -€0.354.
        Is CVS Health Corp overvalued?
        According to Wall Street analysts CVS Health Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does CVS Health Corp pay dividends?
          CVS Health Corp pays a Quarterly dividend of €0.61 which represents an annual dividend yield of 4.16%. See more information on CVS Health Corp dividends here
            What is CVS Health Corp’s EPS estimate?
            CVS Health Corp’s EPS estimate is €1.59.
              How many shares outstanding does CVS Health Corp have?
              Currently, no data Available
              What happened to CVS Health Corp’s price movement after its last earnings report?
              CVS Health Corp reported an EPS of €1.205 in its last earnings report, missing expectations of €1.559. Following the earnings report the stock price went up 3.19%.
                Which hedge fund is a major shareholder of CVS Health Corp?
                Among the largest hedge funds holding CVS Health Corp’s share is Dodge & Cox. It holds CVS Health Corp’s shares valued at 3B.
                  ---

                  Company Description

                  CVS Health Corp

                  Headquartered in Rhode Island and founded in 1963, CVS Health Corp. is a healthcare company in the U.S. that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands.
                  ---

                  1CVS Company Deck

                  ---

                  1CVS Earnings Call

                  Q1 2024
                  0:00 / 0:00
                  ---

                  1CVS Revenue Breakdown

                  52.22%52.22%32.64%29.53%0.13%
                  52.22% Health Services
                  32.64% Pharmacy & Consumer Wellness
                  29.53% Health Care Benefits
                  0.13% Corporate/ Other
                  tipranks
                  ---

                  1CVS Stock 12 Month Forecast

                  Average Price Target

                  €61.72
                  ▲(11.04% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"49":"€49","80":"€80","56.75":"€56.8","64.5":"€64.5","72.25":"€72.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":79.0985,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€79.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":61.7244225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€61.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.3455,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€53.35</span>\n  </div></div>","useHTML":true}}],"tickPositions":[49,56.75,64.5,72.25,80],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.482,53.606346153846154,55.73069230769231,57.85503846153846,59.97938461538462,62.10373076923077,64.22807692307693,66.35242307692307,68.47676923076924,70.60111538461538,72.72546153846154,74.84980769230769,76.97415384615385,{"y":79.0985,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.482,52.269878653846156,53.057757307692306,53.84563596153846,54.63351461538461,55.42139326923077,56.209271923076926,56.997150576923076,57.78502923076923,58.57290788461539,59.36078653846154,60.148665192307696,60.936543846153846,{"y":61.7244225,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.482,51.62534615384615,51.768692307692305,51.91203846153846,52.05538461538462,52.19873076923077,52.342076923076924,52.48542307692308,52.62876923076923,52.77211538461538,52.91546153846154,53.058807692307695,53.20215384615385,{"y":53.3455,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":65.268,"date":1690502400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.074,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.512,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.747,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.801,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.987,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.478,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.952,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.756,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.373,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.869,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.1,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.482,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  CVS Health
                  Walgreens Boots Alliance
                  GoodRx Holdings
                  Cardinal Health
                  UnitedHealth

                  Best Analysts Covering 1CVS

                  1 Year
                  John RansomRaymond James
                  1 Year Success Rate
                  15/28 ratings generated profit
                  54%
                  1 Year Average Return
                  +4.42%
                  reiterated a buy rating 3 months ago
                  Copying John Ransom's trades and holding each position for 1 Year would result in 53.57% of your transactions generating a profit, with an average return of +4.42% per trade.
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis